Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the 2024 PNS Annual Meeting from 22nd to 25th June in Montreal, Canada. This event brings together global experts and specialists in peripheral neuropathy to discuss the latest advancements and research.

Attendees will include clinicians, researchers, and industry professionals dedicated to improving the understanding and treatment of peripheral nerve disorders.

If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.

To find out more, click here.

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event